Trials / Completed
CompletedNCT01579955
Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 321 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is conducted in Japan. The aim of this non-interventional study is to investigate the safety and effectiveness of treatment with eptacog alpha (NovoSeven®) under normal clinical practice conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | eptacog alfa (activated) | Prescription of eptacog alpha at the discretion of the physician |
Timeline
- Start date
- 1999-03-10
- Primary completion
- 2010-03-09
- Completion
- 2010-03-09
- First posted
- 2012-04-18
- Last updated
- 2017-02-24
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01579955. Inclusion in this directory is not an endorsement.